Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria

Laura Diluvio,Arianna Piccolo,Francesco Marasco,Laura Vollono,Caterina Lanna,Barbara Chiaramonte,Cinzia Niolu,Elena Campione,Luca Bianchi

Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria

2020

Laura Diluvio
Arianna Piccolo
Francesco Marasco
Laura Vollono
Caterina Lanna
Barbara Chiaramonte
Cinzia Niolu
Elena Campione
Luca Bianchi

Background: Depression and anxiety are the most common psychiatric comorbidities in chronic spontaneous urticaria (CSU). Omalizumab is a monoclonal antibody approved for CSU treatment. We evaluated...

Keywords:

Anxiety
Monoclonal antibody
Hospital Anxiety and Depression Scale
Internal medicine
Medicine
Omalizumab
psychological status
inflammatory biomarkers

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations